Effect of Pulsatile Flow in Retinal Microvascular Cells
Principal Investigator
Colm O'Brien, MD, FRCS
Mater Misericordiae Hospital (Ireland)
Dublin, Ireland
About the Research Project
Program
Award Type
Standard
Award Amount
$66,000
Active Dates
April 01, 2002 - March 31, 2004
Grant ID
G2002030
Summary
Systemic vascular abnormalities involving impaired regulation of retinal vessels are considered to play a role in glaucoma, particularly low-tension glaucoma (LTG). The vascular supply of the optic nerve head is a capillary network, and factors that affect vascular tone in the endothelial and pericyte cells of this network play a key role in the regulation of optic nerve blood flow. This proposal focuses on examining the effect of hemodynamic forces (pulsatile flow and shear stress) on the retinal vasculature and also on the systemic vessels of LTG patients. Dr. O’Brien is examining the effect of high and low flow rates on the expression of vasodilators and vasoconstrictors in retinal endothelial cells in culture, as well and the effect on signaling pathways in these cells. He is also studying the expression and function of enzymes responsible for the synthesis of vasodilators and vasoconstrictors in systemic vessels obtained from gluteal fat biopsies in LTG patients. He is isolating and co-culturing endothelial and smooth muscle cells from the vessels in LTG patients to study the effects of high and low pulsatile flow rates. The results of these experiments will provide important information of the regulation of vascular tone, and will enhance our understanding of the underlying vascular abnormalities in LTG.
Related Grants
National Glaucoma Research
Mitochondria in Retinal Ganglion Cells
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Rob Nickells, PhD
Current Organization
University of Wisconsin-Madison
Mitochondria in Retinal Ganglion Cells
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Rob Nickells, PhD
Current Organization
University of Wisconsin-Madison
National Glaucoma Research
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dan Stamer, PhD
Current Organization
Duke University School of Medicine
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dan Stamer, PhD
Current Organization
Duke University School of Medicine
National Glaucoma Research
Enhancing Access to Glaucoma Care Using Artificial Intelligence
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Benjamin Xu, MD, PhD
Current Organization
University of Southern California
Enhancing Access to Glaucoma Care Using Artificial Intelligence
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Benjamin Xu, MD, PhD
Current Organization
University of Southern California